Biebermann, H;
Kleinau, G;
Schnabel, D;
Bockenhauer, D;
Wilson, LC;
Tully, I;
Kiff, S;
... Grüters, A; + view all
(2019)
A new multi-system disorder caused by the Gαs mutation p.F376V.
The Journal of Clinical Endocrinology & Metabolism
, 104
(4)
pp. 1079-1089.
10.1210/jc.2018-01250.
Preview |
Text (Accepted manuscript)
Biebermann_jc.2018-01250.pdf - Accepted Version Download (7MB) | Preview |
Preview |
Text (Supplemental Material)
Bockenhauer_A new multi-system disorder caused by the Gαs mutation p.F376V Supplemental Material.pdf - Accepted Version Download (806kB) | Preview |
Abstract
CONTEXT: The α subunit of the stimulatory G protein (Gαs) links numerous receptors to adenylyl cyclase. Gαs, encoded by GNAS, is expressed predominantly from the maternal allele in certain tissues. Thus, maternal heterozygous loss-of-function mutations cause hormonal resistance, as in pseudohypoparathyroidism type Ia, whereas somatic gain-of-function mutations cause hormone-independent endocrine stimulation, as in McCune-Albright syndrome. OBJECTIVE: We report two unrelated boys presenting with a new combination of clinical findings that suggest both gain and loss of Gαs function. DESIGN AND SETTING: Clinical features were studied and sequencing of GNAS was performed. Signaling capacities of wild-type and mutant Gαs were determined in the presence of different G protein–coupled receptors (GPCRs) under basal and agonist-stimulated conditions. RESULTS: Both unrelated patients presented with unexplained hyponatremia in infancy, followed by severe early onset gonadotrophin-independent precocious puberty and skeletal abnormalities. An identical heterozygous de novo variant (c.1136T>G; p.F376V) was found on the maternal GNAS allele in both patients; this resulted in a clinical phenotype that differed from known Gαs-related diseases and suggested gain of function at the vasopressin 2 receptor (V2R) and lutropin/choriogonadotropin receptor (LHCGR), yet increased serum PTH concentrations indicative of impaired proximal tubular PTH1 receptor (PTH1R) function. In vitro studies demonstrated that Gαs-F376V enhanced ligand-independent signaling at the PTH1R, LHCGR, and V2R and, at the same time, blunted ligand-dependent responses. Structural homology modeling suggested mutation-induced modifications at the C-terminal α5 helix of Gαs that are relevant for interaction with GPCRs and signal transduction. CONCLUSION: The Gαs p.F376V mutation causes a previously unrecognized multisystem disorder.
Archive Staff Only
 |
View Item |
